SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Seres Therapeutics Q1 EPS $(0.280), Inline, Sales $8.189M Miss $8.530M Estimate

Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(0.280) per share which met the analyst consensus estimate. This is a 52.54 percent increase over losses of $(0.590) per share from the same period last

Benzinga · 05/07/2020 11:13

Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(0.280) per share which met the analyst consensus estimate. This is a 52.54 percent increase over losses of $(0.590) per share from the same period last year. The company reported quarterly sales of $8.189 million which missed the analyst consensus estimate of $8.530 million by 4.00 percent. This is a 11.86 percent increase over sales of $7.321 million the same period last year.